Unusual 11 Mid-Day Movers 06/13: (GCI) (BLC) (CERE) Higher; (SGOC) (EAC) (DVAX) Lower

June 13, 2013 1:58 PM EDT
Gannett Co., Inc. (NYSE: GCI) 27.6% HIGHER; Gannett and Belo Corp. jointly announced today that they have entered into a definitive merger agreement under which Gannett will acquire all outstanding shares of Belo for $13.75 per share in cash.

Belo Corp. (NYSE: BLC) 27.1% HIGHER; see Gannett above.

Ceres (Nasdaq: CERE) 18.2% HIGHER; has been a hot mover this week into a major catalyst expected later this month or into July. For more color, click here.

LIN TV Corp. (NYSE: TVL) 17.6% HIGHER; moving on Gannett/Belo merger news.

SGOCO Group, Ltd. (Nasdaq: SGOC) 17.6% LOWER; after making a run of over 200 percent the last four trading sessions, traders are taking a little profit today.

Erickson Air-Crane (Nasdaq: EAC) 16.7% LOWER; seeing pressure amid a negative blog post at SeekingAlpha. The author hints at favorable insider dealings for ZM Funds in the recent acquisition of Evergreen Helicopter.

Verastem, Inc., (Nasdaq: VSTM) 12.9% HIGHER; announced that VS-6063 has received orphan medicinal product designation from the European Commission for use in mesothelioma. The designation is to encourage the development of drugs which may provide significant benefit to patients suffering from rare diseases.

Gray Television (NYSE: GTN) 12.7% HIGHER; Gray Television is moving on Belo news today, as well.

Sinclair Broadcast Group Inc. (Nasdaq: SBGI) 12.1% HIGHER; Sinclair Broadcast is moving on Belo news today, as well.

Dynavax Technologies Corp. (Nasdaq: DVAX) 11.6% LOWER; a law firm announced plans to make an investigation into Dynavax following a recent announcement that the U.S. Food and Drug Administration asked for additional safety data on Heplisav. May be adding pressure to shares today.

Echo Therapeutics, Inc. (Nasdaq: ECTE) 11.8% LOWER; seeing a volume drop below the $3.25 support level. Overall, volume on today's session is nearly 10 times the trailing average.

Cornerstone Therapeutics Inc. (Nasdaq: CRTX) 10.8% LOWER; announced that on June 11, 2013 the Company received a Paragraph IV Notice Letter from Exela Pharma Sciences, LLC advising the Company of the filing by Exela of a supplemental New Drug Application seeking approval for a ready to use injectable formulation of 0.1 mg/mL and 0.2 mg/mL nicardipine hydrochloride in 0.9% sodium chloride. The Company markets a ready to use injectable formulation of 0.1 mg/mL and 0.2 mg/mL nicardipine hydrochloride in 0.86% and 0.83% sodium chloride, respectively, under the name CARDENE I.V. (nicardipine hydrochloride) Premixed Injection.

To get this report daily visit http://www.streetinsider.com/entities/Unusual+11+Mid-Day+Movers.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Special Reports

Related Entities

Unusual 11 Mid-Day Movers